Which CLL patients would benefit from intensive therapy?
What do current multiple myeloma clinical trials have in common?
Clinicogenetic risk models to predict outcome of follicular lymphoma patients
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study
How the treatment of AML will change
Mary Frances McMullin